Watchman FLX Implantation for Challenging Left Atrial Appendage Anatomy: Case-Based Discussion

Area of Science:

• Cardiology
• Medical Devices
• Interventional Cardiology

Background:

• Atrial fibrillation (AF) necessitates anticoagulation to prevent stroke.
• Patients with high bleeding risk often cannot tolerate anticoagulation therapy.
• Left atrial appendage (LAA) occlusion devices present an alternative stroke prevention strategy.

Purpose of the Study:

• To evaluate the efficacy and safety of LAA occlusion devices as an alternative to anticoagulation in high-risk AF patients.
• To highlight the advantages of the Watchman FLX device in managing challenging LAA anatomies.
• To present a case series of successful Watchman FLX implantations in patients with complex LAA morphology.

Main Methods:

• Review of existing literature on LAA occlusion devices and anticoagulation in AF.
• Analysis of the design evolution of the Watchman device, focusing on the Watchman FLX.
• Case series presentation of three patients with challenging LAA anatomy who underwent successful Watchman FLX implantation.

Main Results:

• LAA occlusion devices are an acceptable and valid alternative to anticoagulation for high-risk AF patients.
• The Watchman device is non-inferior to oral anticoagulation in preventing cerebrovascular accidents.
• The Watchman FLX device accommodates a wider range of LAA anatomies, including complex and shallow LAA, compared to older generations.

Conclusions:

• LAA occlusion is a viable stroke prevention strategy for high-risk AF patients.
• The Watchman FLX device expands treatment options for patients with challenging LAA anatomy.
• Successful implantation of the Watchman FLX device in complex cases demonstrates its clinical utility.